Optical Coherence Tomography (OCT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. GlobalData's Medical Devices sector report, “Optical Coherence Tomography (OCT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Optical Coherence Tomography (OCT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Optical Coherence Tomography (OCT) report provides key information and data related to:
Extensive coverage of the Optical Coherence Tomography (OCT) under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Optical Coherence Tomography (OCT) pipeline products.
Review of Recent Developments in the segment / industry
The Optical Coherence Tomography (OCT) report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
64,000+ medical equipment company profiles
5,600+ company profiles of medical equipment manufacturers in China and India
2,200+ company profiles of medical equipment manufacturers in Japan
1,200+ companies’ revenue splits and market shares
1,600+ quarterly and annual medical equipment company financials
850+ medical equipment company SWOTs
28,000+ pipeline product profiles
56,400+ marketed product profiles
47,000+ clinical trials
41,500+ trial investigators
7,000+ reports on companies with products in development
44,000+ deals in the medical equipment industry
1,100+ surgical and diagnostic procedures by therapy area
50+ key healthcare indicators by country
431,000+ Themes Content Items
600+ Influencers
1,900+ Analysts & Researchers
0.5m+ Community Members
141,000+ Macroeconomic Indicators
1,013,000+ City Indicators
Scope
Extensive coverage of the Optical Coherence Tomography (OCT) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Optical Coherence Tomography (OCT) Overview
Products under Development
Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Optical Coherence Tomography (OCT) - Pipeline Products by Territory
Table Duke University - Ongoing Clinical Trials Overview
Table Whole Eye Optical Coherence Tomography Scanner - Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study
George Washington University Company Overview
George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table Amplified Bimorph Scanning Mirror System - Product Status
Table Amplified Bimorph Scanning Mirror System - Product Description
Table Retinal Health Monitoring OCT System - A Prospective Study of Patient Based Ophthalmology Suite (PBOS), Inhome Optical Coherence Tomography Device in Patients of Japan
Table Notal Home OCT System - Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision
Table Notal Home OCT System - Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics with Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks
Table Notal Home OCT System - Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
Table Notal Home OCT System - Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD